(lp0
S'Trading Update on Shares of Stereotaxis, Inc.  Baxter Review - 9 hours ago Individual investors might be studying multiple metrics in order to maximize returns. Stereotaxis, Inc.  presently has a Gross Margin  ratio of 1.174998.'
p1
aS'Stereotaxis Announces Multiple Positive Strategic Updates GlobeNewswire  - Sep 27, 2016 ST. LOUIS, Sept. 27, 2016  -- Stereotaxis, Inc. , a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it has signed definitive agreements for multiple ...Stereotaxis secures $24 million in equity financing - St. Louis Business JournalStereotaxis announces new investors, board members - STLtoday.com'
p2
aS'Stereotaxis Inc  Hits The OTC Insider Financial - Aug 8, 2016 Stereotaxis Inc  is the latest NASDAQ stock to get de-listed and relegated to the OTC Markets, or the land of penny stocks.'
p3
aS'Stereotaxis Completes Private Placement of $24 Million GlobeNewswire  - Sep 29, 2016 ST. LOUIS, Sept. 29, 2016  -- Stereotaxis, Inc. , a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it has closed its previously announced private placement&nbsp;...'
p4
aS'Stereotaxis Inc  Explodes Up The Charts Insider Financial - Apr 5, 2016 Shares of Stereotaxis Inc  have exploded up the chart after news that a US hospital completed more than 1000 procedures using its Niobe system.'
p5
aS'Numbers in Review for Stereotaxis Inc  Providence Standard - 11 hours ago Keeping an eye on moving averages for Stereotaxis Inc , the 50-day is 0.64, the 200-day is at 0.77, and the 7-day is 0.59.'
p6
aS'Stereotaxis: A Good Opportunity For Risk-Tolerant Investors Seeking Alpha - Aug 16, 2013 This is the industry Stereotaxis Inc.  operates in. One thing about Stereotaxis is that as a small-cap company, it did what small-cap companies usually do in order to survive in a competitive industry - specializing in a few segments ...'
p7
aS'Clinical Study Validates Efficiencies of Stereotaxis Niobe ES System Compared ... GlobeNewswire  - Mar 14, 2017 ST. LOUIS, March 14, 2017  -- Stereotaxis, Inc. , a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported results of a study conducted at Centre Hospitalier Universitaire&nbsp;...'
p8
aS'STEREOTAXIS, INC.  Files An 8-K Departure of Directors or ... Market Exclusive - Mar 2, 2017 The Stereotaxis platform helps physicians to provide patient care with robotic precision and enhanced integration of procedural information.'
p9
aS'Stereotaxis Inc. appoints Dr. Gery Tomassoni as chief medical officer STLtoday.com - Aug 10, 2012 St. Louis-based Stereotaxis Inc. appointed Dr. Gery Tomassoni, a physician, to a three-year term as its chief medical officer.'
p10
a.